SAGE Therapeutics Inc (SAGE) stock has fallen -69.63% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives SAGE stock a score of 28 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 3. SAGE's rank also includes a long-term technical score of 20. The fundamental score for SAGE is 61. In addition to the average rating from Wall Street analysts, SAGE stock has a mean target price of 69.611. This means analysts expect the stock to increase 38.45% over the next 12 months.
What's Happening with SAGE Stock Today
SAGE Therapeutics Inc (SAGE) stock has fallen -2.12% while the S&P 500 has gained 1.32% as of 2:25 PM on Wednesday, Aug 12. SAGE has fallen -$1.09 from the previous closing price of $51.37 on volume of 515,334 shares. Over the past year the S&P 500 is higher by 15.43% while SAGE has fallen -69.63%. SAGE lost -$11.80 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on SAGE Therapeutics Inc (SAGE) Stock.